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Abstract 
Hereditary spherocytosis (HS) and sickle cell disease (SCD) are associated with 
splenomegaly and spleen dysfunction in pediatric patients. Scant data exist on possible correlations 
between spleen morphology and function in HS and SCD. This study aimed to assess the 
histological and morphometric features of HS and SCD spleens, in order to get possible correlations 
with disease pathophysiology. In a large series of spleens from SCD, HS and control patients the 
following parameters were considered: (i) macroscopic features; (ii) lymphoid follicle (LF) density; 
(iii) presence of peri-follicular marginal zones (MZs); (iv) presence of Gamna-Gandy bodies; (v) 
density of CD8-positive sinusoids; (vi) density of CD34-positive microvessels; (vii) 
presence/distribution of fibrosis and SMA-positive myoid cells; (viii) density of CD68-positive 
macrophages. SCD and HS spleens have similar macroscopic features. SCD spleens had lower LF 
density and fewer MZs than HS spleens and controls. SCD also showed lower CD8-positive 
sinusoid density, increased CD34-positive microvessel density and SMA-positive myoid cells, and 
higher prevalence of fibrosis and Gamna-Gandy bodies. HS had lower LF and CD8-positive 
sinusoid density than controls. No significant differences were noted in red pulp macrophages. By 
multivariate analysis, the majority of HS spleens clustered with controls, while SCD grouped 
separately. A multi-parametric score could predict the degree of spleen changes irrespective of the 
underlying disease. In conclusion, SCD spleens display greater histologic effacement than HS and 
SCD-related changes suggest impaired function due to vascular damage. These observations may 
contribute to guide the clinical management of patients. 
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1. Introduction 
 The spleen is the largest organ of the lymphatic and reticuloendothelial system and its 
functions include blood cell storage, hemocatheresis and immune response against blood-borne 
infections (1). These functions are sustained by two topographically and functionally distinct 
compartments: the white pulp and the red pulp (2). 
 The white pulp consists of periarterial sheaths of lymphocytes with evenly distributed 
lymphoid follicles (LFs). Both primary and secondary LFs display an outer marginal zone (MZ), 
composed of small to medium size lymphocytes with abundant cytoplasm. MZ lymphocytes exert a 
pivotal role in immune responses against polysaccharide-encapsuled bacteria (i.e. S. pneumoniae, 
N. meningitidis and H. influenzae) (3-5). The red pulp consists of sinusoids surrounded by a 
meshwork of macrophages with interlacing cytoplasmic processes (red pulp cords). The histological 
and ultra-structural features of the red pulp allow the filtration of circulating blood cells and the 
removal of senescent and/or damaged erythrocytes (1, 2).  
Several hematological disorders can alter the microscopic features of the spleen, with 
consequent damage to its immunologic and non-immunologic functions. Hereditary spherocytosis 
(HS) and sickle cells disease (SCD) are rare congenital diseases, characterized by distinct 
pathogenic mechanisms and associated with variable spleen dysfunction (6, 7). HS is a genetic 
disorder of the erythrocyte cytoskeleton, causing abnormal red blood cell (RBC) shape, loss of RBC 
membrane and chronic hemolysis (8). The spleen is the main site of RBCs disruption, as 
spherocytes can hardly squeeze through the splenic sinusoids and are entrapped in the red pulp 
cords (1). This causes moderate to severe splenomegaly, which is typically associated with anemia, 
reticulocytosis, jaundice and increased risk of gallstones. Splenectomy improves HS-related 
symptoms in the majority of cases (6, 9).  
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SCD is a hereditary disorder caused by a point mutation on the β-globin gene, inducing a 
glutamic acid to valine substitution at position 6 (10). The resulting hemoglobin (i.e. hemoglobin S 
[HbS]) is characterized by peculiar biochemical properties. It indeed displays a hydrophobic motif, 
which prompts the aggregation and precipitation of de-oxygenated hemoglobins in RBCs (11). The 
precipitates promote the acquisition of a sickle-like shape, induce RBC hemolysis and cause the 
entrapment of sickle cells in small vessels and capillary networks (12). This leads to both intra-
vascular and extra-vascular hemolysis, with vaso-occusive crises, microvascular thrombosis and 
ischemic damage to several organs. SCD is indeed characterized by a broad spectrum of clinical 
manifestations, including pain crises, renal papillary necrosis, ischemic strokes and bacterial 
infections. The latter are supposed to be mainly caused by the progressive shrinking of the spleen 
(i.e. functional asplenia) possibly due to recurrent ischemic accidents of the red pulp (7). In SCD, 
the spleen can also be involved by acute sequestration crises, which are characterized by a 
precipitous drop in hemoglobin concentration, reticulocytosis and tender splenomegaly (13, 14). 
The morphological and pathophysiological bases of spleen dysfunction in HS and SCD are 
not fully described. Their better understanding may however contribute to improve the clinical 
management of patients. In the present study, the histological features of HS and SCD spleens have 
been characterized by thorough morphometric and immunohistochemical analysis. The histological 
results also allowed the develpment of a multi-parametric score to assess the severity of splenic 
changes in each single case. 
 
2. Materials & Methods 
2.1 Case selection 
 This retrospective, multi-institutional study considered a series of 42 spleens from pediatric 
patients (mean age: 8.6 years; M:F ratio: 1.2) with HS and SCD, who underwent partial or total 
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splenectomy for disease-related splenomegaly/hypersplenism. In detail, the following cases were 
considered: (i) 35 spleens from children with HS (total splenectomy: 32 cases; partial splenectomy: 
3 cases); (ii) 7 spleens from children with SCD (total splenectomy in all cases; all spleens were 
removed as a consequence of previous sequestration crises); (iii) 10 control spleens removed for 
traumatic rupture in pediatric patients (total splenectomy in all cases). The gross description (spleen 
weight; presence of sub-capsular infarcts; thrombosis of hilar vessels) and clinic-epidemiological 
data were available in all cases (Table 1). 
 Paraffin embedded tissue blocks were retrieved from the archives of the Surgical Pathology 
& Cytopathology Unit of Padova University Hospital (Padova, Itay), the Hematopathology Unit of 
Bologna University Hospital (Bologna, Italy) and the Ospedale Pediatrico Bambino Gesù (Rome, 
Italy). All cases were reviewed by two pathologists (LS and MP) and representative tissue sections 
were selected for morphometric and immunohistochemical analyses. The ethic regulations on 
research on human tissues were followed by each of the participating Centers, consistent with the 
declaration of Helsinki. 
2.2 Histologic evaluation of the spleen 
 Representative formalin-fixed, paraffin-embedded tissue blocks were assessed for the 
following morphological and morphometric parameters: (i) white pulp architecture and LF density 
(i.e. number of LFs per square unit); (ii) presence/absence of a peri-follicular MZ; (iii) presence of 
Gamna-Gandy bodies (i.e. sclero-siderotic nodules); (iv) presence of splenic fibrosis (assessed by 
reticulin stain and defined as the presence of reticulin fibers exceeding those normally observed 
around splenic vessels and red pulp sinusoids); (v) density of CD8-positive sinusoids (i.e. mean 
number of cross-sectioned CD8-positive vessels per 10 high-power fields); (vi) density of CD34-
positive red pulp vessels (i.e. mean number of cross-sectioned CD34-postive vessels per 10 high-
power fields); (vii) density of CD68-positive red pulp macrophages (mean number of CD68-postive 
cells per 10 high-power fields); (viii) presence and distribution of SMA-positive myoid cells. 
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 The morphometric parameters (i.e. FL density, CD8-positive vessel density, CD34-positive 
vessel density, and CD68-positive macrophage density) were manually evaluated using the 
DMD108 Digital Micro-imaging Device and Software (Leica Microsystems, Milano, Italy). 
2.3 Immunohistochemical analysis  
 Splenic stroma and red pulp vessels were immunohistochemically studied with primary 
antibodies against the following antigens: (i) CD34 (clone QBEnd/10, Leica; Newcastle, United 
Kingdom); (ii) CD8 (clone C8/144B, Dako; Glostrup, Denmark); (iii) Smooth Muscle Actin (SMA, 
clone 1A4, Dako); (vi) CD68 (clone PGM1, Dako). Antigen detection was performed using an 
automated immunostainer (Bond-maX; Leica, Newcastle Upon Tyne, UK), as previously described 
(15). In SCD and HS cases, the number of SMA-positive stromal cells was assessed by comparison 
with control spleens and graded as increased, normal, or reduced. 
2.4 Statistical analysis 
Comparison of the histological variables was performed by both univariate and multivariate 
analyses using IBM Spss Statistics 20.0 (IBM, Armonk, USA). For univariate analysis, differences 
among groups were evaluated by the Fisher’s exact test (qualitative variables) and the Student t-test 
(quantitative variables). Differences were considered statistically significant for values of p< 0.05.  
Multivariate analysis was performed using the histological variables, which were 
statistically different by univariate analysis. The principal component analysis (PCA) was applied to 
reduce the number of observed parameters, creating a list of factors (components) as a linear 
combinations of the original variables. The total amount of variance explained by the first 3 
principal components is 84.1%.  
K-mean cluster analysis was used to stratify and classify the spleens according to the 
histological findings (16). Briefly, K-mean cluster algorithm iteratively evaluates the cluster center 
for every histological variable and assigns every sample to the closest cluster, according to the 
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Euclidean distance between each observed histological value and its relative cluster center. Each 
variable was thus given a dichotomic value (0 versus 1), based on thresholds defined by a k-means 
clustering algorithm (Table 2). The sum of such values was then calculated and cases were clustered 
according to the obtained score. The results were graphically represented by a heatmap using MeV 
v4.7.4 software (17).  
 
3. Results 
3.1 Macroscopic and histological features of HS spleens 
 Among children with HS (mean age: 8.72 years; M:F ratio: 0.9), the spleens removed by 
total splenectomy were significantly larger than controls (mean spleen weight: 381.3 g in the HS 
subgroup; 130.6 g in the control subgroup) (Student’s t-test, p<0.01). Gross examination did not 
reveal sub-capsular infarcts and/or thrombosis of the hilar vessels. 
 Histological examination of HS spleens disclosed preserved white pulp architecture, with 
primary and secondary follicles surrounded by a clear-cut MZ (34/35 cases). HS spleens were 
however characterized by a lower LF density compared to controls (mean LF density: 0.3/mm
2
 in 
HS spleens; 0.6/mm
2
 in control spleens) (Student’s t-test, p<0.01) (Figure 1; Table 1). 
The majority of HS spleens had preserved red pulp architecture, with no evidence of fibrosis 
and/or Gamna-Gandy bodies. Similar results were reported in control spleens (Fisher’s exact test; 
no statistically significant differences) (Figure1; Table 1). Of note, HS was characterized by 
decreased numbers of CD8-positive sinusoids compared to normal controls (mean sinusoid density: 
47.3/HPF in HS; 57.4/HPF in normal spleens) (Student’s t-test, p<0.01). Differences in CD34-
positive microvessels were not statistically significant (mean microvessel density: 43.5/HPF in HS; 
45.2/HPF in normal spleens) (Student’s t-test, p=0.38) (Table 1; Figure 2). In 33/35 HS cases, the 
number and distribution of SMA-positive myoid cells overlapped the pattern observed in normal 
controls. An increase of SMA-positive myoid cells was only documented in 2 cases, which were 
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also characterized by red pulp fibrosis. In these cases, the distribution of SMA-positive myoid cells 
roughly paralleled the extent and distribution of reticulin fibers (Figure 2). No significant 
differences in the density of CD68-positive macrophages were noted between HS spleens and 
control cases (mean macrophage density: 64.1/HPF in HS; 65.3/HPF in normal spleens) (Student’s 
t-test, p=0.49). 
 
3.2 Macroscopic and histological features of SCD spleens 
 SCD cases included 7 children, who underwent total splenectomy for disease-related 
complications (mean age at splenectomy: 6.4 years; M:F ratio: 2.0). The mean weight of SCD 
spleens (427.6 g) was significantly higher than in normal controls (Student’s t-test, p<0.01). On 
gross examination, there was no evidence of infarcts and/or thrombosis of the hilar vessels. 
 Histologic examination disclosed marked alterations of the white pulp, with only scattered 
lymphoid follicles, mostly devoid of well-formed MZs (mean LF density: 0.1/mm
2
; presence of 
MZ: 2/7 cases). Differences in white pulp architecture between SCD and control spleens were 
statistically significant (Student’s t-test and Fisher’s exact test, p<0.01) (Figure 1; Table 1). 
SCD spleens also disclosed marked alteration of the red pulp, with increased reticulin 
deposition in 6/7 cases. Gamna-Gandy bodies were present in all the examined samples. The 
density of CD8-positive sinusoids in SCD was markedly reduced compared to normal controls 
(mean sinusoid density in SCD: 26.2/HPF) (Student’s t-test, p<0.01). Conversely, the number of 
CD34-positive microvessels was higher in SCD than control spleens (mean CD34-positive 
microvessel density: 64.3/HPF in SCD) (Student’s t-test, p=0.05). Overall, 6/7 SCD spleens 
disclosed a significant increase of SMA-positive myoid cells compared to controls (Fisher exact 
tests, p<0.01) (Table 1; Figure 2). Like in HS, the number and distribution of SMA-positive myoid 
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cells paralleled reticulin fibrosis. Similar CD68-positive cell density was reported between SCD and 
control spleens (mean macrophage density: 66.0/HPF in SCD) (Student’s t-test, p=0.88). 
 
3.2 Comparison between HS and SCD spleens 
By univariate analysis, SCD disclosed lower LF density and less MZ formation than HS 
spleens (Student’s t-test and Fisher’s exact test, p<0.01). SCD spleens featured higher incidence of 
red pulp fibrosis and Gamna-Gandy bodies (Fisher’s exact test, p<0.01). They were also 
characterized by lower CD8-positive sinusoid density and higher CD34-positive microvessel 
density (Student’s t-test, p<0.05; Figure 3). An increase of SMA-positive myoid cells was more 
frequently observed in SCD than HS (Fisher’s exact test, p<0.01; Figure 3), while no differences in 
CD68-positive cell density were noted (Fisher’s exact test, p=0.51) (Table 1). 
 The overall histological features of SCD, HS and control spleens were also evaluated by 
means of PCA, a multivariate procedure clustering cases according to a linear combination of 
histological parameters. This analysis disclosed sharply distinct grouping of HS and SCD spleens. 
In particular, all but 2 HS spleens clustered in close proximity to control spleens. On the contrary, 
SCD spleens formed a distinct group, which also included the 2 outlier cases of HS (Figure 4A). 
Taken together, these results demonstrate that HS and SCD spleens have distinct histological 
features at both univariate and multivariate analysis. The latter also demonstrates that the overall 
histological features of HS spleens are closer to normal controls than SCD. 
 
3.3 Multi-parametric score to predict the severity of spleen histological changes 
 The finding that HS and SCD spleens form sharply distinct clusters with occasional outliers 
prompted us to develop a histologic score to assess the severity of the splenic changes, irrespective 
of the original diagnosis. This score would objectively stratify spleens based on their deviation from 
normal controls and may prove useful for both research and clinical purposes.  
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 The score was calculated using a k-mean clustering algorithm (Table 2) and the obtained 
results were clustered accordingly (Figure 4B). This statistical procedure revealed that scores ≥3 
predict marked deviation from controls and are thus suggestive of severe spleen damage. In 
particular, high scores were reported in all SCD (score= 7: 4 cases; score= 6: 1 case; score= 4: 1 
case; score= 3: 1 case), and in 2 HS (score= 3) spleens. Low scores were instead reported in 33 HS 
(score=1 in 1 case; score= 0 in 32 cases) and in all controls (score= 0 in all cases). 
 
5. Discussion 
HS and SCD are congenital hematological disorders with different etiological and 
pathophysiological features. Seminal studies have investigated the morphological features of the 
spleen in HS and SCD, disclosing a reduction of the white pulp and variable congestion of the red 
pulp (1, 2, 18-24). SCD (but not HS) has also been associated with sub-capsular infarcts and sclero-
siderotic nodules of the red pulp (i.e. Gamna-Gandy bodies) (1, 25). Of note, the majority of such 
studies was performed before the introduction of immunohistochemical techniques and lacked a 
thorough characterization of the splenic anatomic and functional components. Based on this 
preliminary evidence, the present study aimed to investigate the morphological, 
immunohistochemical and morphometric changes of a series of HS and SCD. 
Spleens in children with HS and SCD were markedly enlarged compared to controls, but did 
not show any focal lesion and/or major vascular thrombosis. Such a significantly increased volume 
is probably attributable to marked red pulp congestion (i.e. spherocyte entrapment within red pulp 
sinusoids in HS; marked red pulp congestion due to prior sequestration crises in SCD). At histology, 
SCD spleens were characterized by significant alteration of the white pulp, with low LF density and 
absence of MZs in the majority of cases. The decreased LF density could at least partially be 
explained by the congestion and expansion of the red pulp sinusoids. On the other hand, the absence 
of well-formed MZs in SCD is in keeping with the clinical observation of impaired immunologic 
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functions against bloodborne bacteria (7). The latter may also be related to severe impairment of red 
pulp vessels, which exert a pivotal role in blood filtration and bacteria culling. 
SCD was indeed associated with reduced CD8-positive sinusoid density, increased CD34-
positive microvessel density, higher incidence of red pulp fibrosis and Gamna-Gandy bodies (Table 
1; Figure 1 and Figure 2). The distribution of SMA-positive myoid cells paralleled the extent of 
fibrosis, indicating a possible role for these cells in the deposition of reticulin fibers. These findings 
suggest the occurrence of chronic micro-vascular accidents within the red pulp (thrombosis and/or 
vasculopathy), ultimately leading to effacement of the red pulp vessels and to the development of 
red pulp fibrosis. Vasculopathy is indeed a well known pathogenic mechanism of SCD-related 
organ damage, being responsible of brain, lung and kidney dysfunction (26-29). Our findings may 
imply the importance of these changes even for SCD-related spleen impairment. The young age of 
our patients also suggests that such pathogenic events occur very early in the natural history of the 
disease.  
HS spleens were characterized by less severe histological derangements. The white pulp 
indeed disclosed normal lymphoid cuffs, with well-preserved LFs and clear-cut MZs. This 
observation is in keeping with previously reported data, which documented the preservation of the 
lymphoid architecture in HS spleens (1). Of note, our study also disclosed a reduction of FL density 
and CD8-positive sinusoids in HS (Table 1; Figure 1 and 2). Such observations (never reported 
before) may indicate some impairment of spleen physiology in HS. The degree of these changes 
seems however too small to bear any clinical consequence. 
No differences were noted in the number of red pulp macrophages among HS, SCD and 
control spleens. This finding contrasts with previous ultra-structural studies, reporting increased 
splenic cord macrophages in HS compared to normal spleens (19, 22). Such a discrepancy may be 
in part related to the use of different techniques (CD68 immunohistochemistry on whole tissue 
sections versus electron microscopy on small splenic samples), but further studies are needed to 
clarify this issue. In this context, it may also be useful to correlate the histological findings with the 
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results of nuclear imaging studies (i.e. 
99m
Tc-labeled sulfur-colloid test and/or 
99m
Tc-labeled heat-
damaged red blood cells test) (30). This would indeed contribute to better characterize the 
morphological-functional status of the reticuloendothelial system in HS and SCD spleens.  
From a pathogenic perspective, the SCD-induced red pulp effacement deserves special 
consideration. SCD is a chronic hemolytic disorder characterized by severe vascular damage and 
widespread endothelial injury (7, 31). One of the key mediators of such processes is free serum 
heme, which is released from HbS upon sickle cell lysis (32, 33). Free serum heme binds to surface 
TLR4 of endothelial cells and triggers a cascade of deranged signaling pathways, which ultimately 
lead to endothelial cell dysfunction and vasculopathy (32). In SCD, it is thus conceivable that 
chronic vascular occlusion, RBC hemolysis, and heme release induce severe injury of the splenic 
sinusoids, with red pulp fibrosis and proliferation of non-specialized CD34-positive microvessels. 
This hypothesis may also explain the less severe changes observed in HS. Pure HS is indeed 
characterized by un-mutated hemoglobin genes, which are significantly less prone to release free 
heme after RBC lysis (31, 32, 34). 
The observation of severe spleen damage in a small subset of HS patients led us to develop a 
multi-parametric score to assess the severity of spleen damage irrespective of the underlying disease 
(Table 2; Figure 4B). This score effectively stratified spleens according to reproducible and easily 
assessable parameters and may prove useful for both research and clinical purposes.  
As for its research applications, the histological score would enable to objectively grade the 
severity of spleen impairment, allowing the comparison with other clinical, laboratory and/or 
radiological data. It may thus contribute to better delineate the pathophysiology and clinical-
pathological correlations of several spleen disorders. From a clinical perspective, this score may 
impact on the management of patients in specific clinical settings, such as after partial splenectomy. 
In this context, the grading of spleen changes may indeed help assess the morphological-functional 
status of the residual spleen, thus allowing the planning of adequate post-surgical therapies. Such 
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clinical applications are however still speculative and need to be investigated by future clinical-
pathological studies. 
In conclusion, this study demonstrates different patterns of spleen damage in HS and SCD. 
These differences may result from diverse pathogenic mechanisms (extra-vascular hemolysis in HS; 
intra-/extra-vascular hemolysis and microvascular damage in SCD) and may provide hints for the 
management of patients. The development of a multi-parametric score to assess spleen effacement 
contributes to this aim and represents a tool for future research on spleen dysfunction in 
hematological and non-hematological disorders. 
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FIGURE LEGENDS 
 
Figure 1. Histological features of HS, SCD and control spleens. 
A-C. The spleens from patients with HS were characterized by preservation of the white 
pulp, with well-preserved marginal zones (A). The red pulp was congested (B) with no evidence of 
reticulin fiber deposition (C).  
D-F. The spleens from patients with SCD disclosed altered lymphoid follicles (i.e. reduced 
density; absence of marginal zones) (D), numerous Gamna-Gandy bodies (E) and red pulp fibrosis 
(F).  
G-I. Control spleens showed well-developed secondary follicles, with clear-cut marginal 
zones (G). The red pulp was unremarkable, with no increase in reticulin fibers (H-I). (H&E and 
Reticulin stain; original magnification, x20). 
 
Figure 2. Immunohistochemical features of HS, SCD and control spleens. 
A-C. The spleens from patients with HS were characterized by a slight reduction of CD8-
positive red pulp sinusoid (A) and by a normal distribution of CD34-positive microvessels (B). In 
the majority of cases, SMA-positive myoid cells were normally represented (C).  
D-F. SCD spleens disclosed a sharp reduction of CD8-positive sinusoids (D), with a parallel 
increase of both CD34-positive microvessels (E) and SMA-positive myoid cells (F).  
G-I. Control spleens showed a dense network of CD8-positive sinusoids (G), with sparse 
CD34-positive microvessels (H) and SMA-positive myoid cells (I). (Peroxidase stain; original 
magnification, x20). 
 
Figure 3. Comparison of the histological features in the studied spleens. 
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A-C. Univariate analysis disclosed significantly higher lymphoid follicle (LF) density (A) 
and CD8-positive sinusoid density (B) in control spleens compared to both SCD and HS spleens. 
CD34-positive microvessels were more abundant in SCD than in HS and controls (C) (Student’s t-
test). D-F. Marginal zones were more frequently documented in HS and control spleens compared 
to SCD (D). By contrast, Gamna-Gandy bodies and red pulp fibrosis were more frequent in SCD 
(the blotted values refer to the percentage of positive and negative cases for each group; Fisher 
exact test) (Notes: * p<0.01; ** p<0.05).  
 
Figure 4. Multivariate analysis of the histological features in the studied spleens. 
A. Primary component analysis clustered the spleens according to a linear combination of 
histological parameters. The analysis disclosed that the majority of HS grouped together with 
controls, while all SCD and 2 HS spleens formed a distinct cluster. 
B. K-mean cluster analysis was applied to classify the spleens, irrespective to the original 
diagnosis. Each case was stratified according to dichotomic values attributed to the histological 
variables (red square: score 1; green square: score 0). The combination of such values led to the 
identification of 2 sharply distinct clusters: one (left side of the plot) grouped all the control spleens 
and the majority of HS cases; the other (right side of the plot) grouped 6/7 SCD spleens and 2 
outlier HS. In the heatmap, each row represents a histological parameter and each column 
represents a sample. 
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Table 1. Clinical-epidemiological and histological features of the studied spleens 
 Hereditary  
Spherocytosis 
Sickle Cell 
Disease 
Control  
Spleens 
HS vs 
SCD 
(p 
value) 
HS vs 
Ctrl 
(p 
value) 
SCD vs 
Ctrl 
(p value) 
Mean age at splenectomy 
(years) 
8.7 ±1.2 6.4 ±1.7 9.6 ±3.4 n.s n.s n.s 
Mean spleen weight (gr) 381.3 ±74.7 427.6 ±167.3 130.6 ±40.7 n.s <0.01 0.03 
Lymphoid follicle density 
(no/mm
2
) 
0.3 ±0.03 0.1 ±0.06 0.6 ±0.10 <0.01 <0.01 <0.01 
CD8-positive sinusoid 
density (no/HPF) 
47.3 ±7.1 26.2 ± 17.5 57.4 ±2.9 <0.01 <0.01 <0.01 
CD34-positive vessel 
density (no/HPF) 
43.5 ±7.7 64.3 ±24.3 45.2 ±2.7 0.04 n.s. 0.05 
Gamna-Gandy bodies 1/35 7/7 0/10 <0.01 n.s <0.01 
Presence of white pulp 
marginal zones 
34/35 2/7 10/10 <0.01 n.s. <0.01 
Presence of red pulp 
fibrosis 
2/35 6/7 0/10 <0.01 n.s. <0.01 
Increased SMA-positive 
myoid cells 
2/35 6/7 0/10 <0.01 n.s <0.01 
Red pulp macrophage 
density (no/HPF)* 
64.1±1.3 66.0 ± 2.0 65.3 ±3.3 n.s n.s n.s 
* the number of red pulp macrophages was assessed by CD68 immunohistochemical stain. 
Note: Ctrl= control HPF= high-power field; HS= hereditay spherocytosis; SCD= sickle cell disease 
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Table 2. Thresholds for the assessment of the histological score (k-means algorithm) 
 score 0 score 1 
Lymphoid follicle density ≥ 0.2 < 0.2 
CD8-positive sinusoid density ≥35.9  <35.9 
CD34-positive vessel density <56.5  ≥56.5 
Fibrosis Absent Present 
Marginal zones Present Absent 
Gamna-Gandy bodies Absent Present 
SMA pattern Normal  Increased 
 
 
